Since mid-February, Meta Platforms has unveiled multi-year strategic partnerships with leading chipmakers Nvidia and AMD, underscoring an ambitious US$100 billion capital expenditure plan for 2026.

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Fintel reports that on December 17, 2025, JP Morgan upgraded their outlook for Recursion Pharmaceuticals (NasdaqGS:RXRX) from Neutral to Overweight. Analyst Price Forecast Suggests 37.89% Upside As of ...

French AI startup Mistral has weathered a rocky period of public questioning over the last year to emerge, now here in December 2025, with new, crowd-pleasing models for enterprise and indie ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Add a description, image, and links to the javascript-2 topic page so that developers can more easily learn about it.

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with two-way interactions between predictor variables. Standard linear regression predicts a single numeric value ...

Many saw desktop impressions drop around Sept. 10. A working theory is that past spikes were inflated by bots loading 100-result pages. Google hasn’t commented yet. Google appears to have disabled the ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.41187 EPS, ...